Published in FEBS Lett on February 03, 1997
Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr (2008) 1.10
ACE inhibitory activity of pangasius catfish (Pangasius sutchi) skin and bone gelatin hydrolysate. J Food Sci Technol (2012) 0.89
Identification of the major ACE-inhibitory peptides produced by enzymatic hydrolysis of a protein concentrate from cuttlefish wastewater. Mar Drugs (2014) 0.86
Discordance between in silico & in vitro analyses of ACE inhibitory & antioxidative peptides from mixed milk tryptic whey protein hydrolysate. J Food Sci Technol (2014) 0.86
Bioactive peptides of animal origin: a review. J Food Sci Technol (2015) 0.82
Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis. Br J Clin Pharmacol (2016) 0.78
Health-Related Aspects of Milk Proteins. Iran J Pharm Res (2016) 0.75
The γ-aminobutyric acid-producing ability under low pH conditions of lactic acid bacteria isolated from traditional fermented foods of Ishikawa Prefecture, Japan, with a strong ability to produce ACE-inhibitory peptides. Biotechnol Rep (Amst) (2016) 0.75
A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol (1995) 3.35
[The taxonomic problem of Clostridium sordellii and Clostridium bifermentans]. Med Dosw Mikrobiol (1966) 1.72
Indigenous hepatitis E virus infection of a plasma donor in Germany. Vox Sang (2009) 1.60
Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia. J Virol (1999) 1.54
Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species. J Med Virol (2001) 1.42
Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut (2009) 1.40
Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur J Clin Microbiol Infect Dis (1995) 1.28
Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr (2000) 1.22
Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol (1996) 1.21
Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology (1997) 1.20
Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. J Virol (1997) 1.17
Core particles of hepatitis B virus as carrier for foreign epitopes. Adv Virus Res (1998) 1.17
Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr Pharm Des (2007) 1.16
Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology (1992) 1.15
Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol (2001) 1.14
Lack of uniformity in the clinical approach to the interpretation of urinary catecholamines and their metabolites. Ir J Med Sci (1995) 1.11
Short report: simultaneous occurrence of Dobrava, Puumala, and Tula Hantaviruses in Slovakia. Am J Trop Med Hyg (1999) 1.11
Antioxidative peptides: enzymatic production, in vitro and in vivo antioxidant activity and potential applications of milk-derived antioxidative peptides. Amino Acids (2012) 1.08
Phaeochromocytoma--a laboratory experience. Ir J Med Sci (1995) 1.07
Human cytomegalovirus (HCMV) encephalitis in an immunocompetent young person and diagnostic reliability of HCMV DNA PCR using cerebrospinal fluid of nonimmunosuppressed patients. J Clin Microbiol (1998) 1.05
Clinical characterization of Dobrava hantavirus infections in Germany. Clin Nephrol (2001) 1.04
Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des (2003) 0.99
Genetic characterization of a new hantavirus detected in Microtus arvalis from Slovakia. Virus Genes (1995) 0.95
Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease. Hepatology (1996) 0.94
Heterogeneity of hepatitis B virus C-gene sequences: implications for amplification and sequencing. J Hepatol (1993) 0.94
Life-threatening Dobrava hantavirus infection with unusually extended pulmonary involvement. Clin Nephrol (2004) 0.93
Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Nahrung (1995) 0.93
Nucleosides and nucleotides: natural bioactive substances in milk and colostrum. Br J Nutr (2000) 0.91
Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Lett (1996) 0.90
Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J Gen Virol (2000) 0.90
Detection of human hantavirus infections in Lithuania. Infection (2005) 0.90
Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine (1998) 0.90
[Prevalence of hantavirus infections in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2004) 0.90
Comparative inhibition of hepatitis B virus DNA polymerase and cellular DNA polymerases by triphosphates of sugar-modified 5-methyldeoxycytidines and of other nucleoside analogs. Antimicrob Agents Chemother (1991) 0.88
Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotype. Arch Virol (1995) 0.88
Opioid peptides encrypted in intact milk protein sequences. Br J Nutr (2000) 0.88
Mapping of B-cell epitopes in the nucleocapsid protein of Puumala hantavirus. Viral Immunol (2002) 0.88
Modification of the furanacryloyl-L-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity. J Biochem Biophys Methods (2004) 0.87
A rapid slide agglutination test contrasted with a radioimmunoassay for myoglobin measurement for the early diagnosis of myocardial necrosis. Ir J Med Sci (1988) 0.87
Rational use of diagnostic tools in hepatitis C. J Hepatol (1996) 0.87
Lactokinins: whey protein-derived ACE inhibitory peptides. Nahrung (1999) 0.86
HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein. Biol Chem (1999) 0.86
New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge. J Biotechnol (1999) 0.86
The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid. Postgrad Med J (1995) 0.86
Transmission of GBV-C/HGV from drug-addicted mothers to their babies. J Hepatol (1997) 0.85
Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity. Virology (1998) 0.85
Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions. J Gen Virol (1999) 0.85
Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection. J Hepatol (1999) 0.83
Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1. Virology (1998) 0.83
Automated bed to aid pulmonary drainage and prevent decubitus ulcers. Med Biol Eng (1975) 0.82
Treatment of chronic hepatitis B with interferon alfa-2b. J Hepatol (1990) 0.82
Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association? Ann Hematol (2000) 0.82
Caseinophosphopeptides and their cell modulating potential. Biofactors (2004) 0.82
Chemical characterization and opioid activity of an exorphin isolated from in vivo digests of casein. FEBS Lett (1986) 0.82
Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles. Virology (2000) 0.81
Enzymatic hydrolysis of heat-induced aggregates of whey protein isolate. J Agric Food Chem (2012) 0.81
First molecular evidence for Puumala hantavirus in Slovakia. Virus Genes (2001) 0.81
[Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population]. Gesundheitswesen (1999) 0.80
Hydrolysis of alphas1- and beta-casein-derived peptides with a broad specificity aminopeptidase and proline specific aminopeptidases from Lactococcus lactis subsp. cremoris AM2. FEBS Lett (1999) 0.80
Sensory ataxia in myelopathy with chronic hepatitis C virus infection. Neurology (2002) 0.80
Leg load warning system for the orthopaedically handicapped. Med Biol Eng (1974) 0.80
DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection. J Biotechnol (2001) 0.80
In vitro bioactive properties of intact and enzymatically hydrolysed whey protein: targeting the enteroinsular axis. Food Funct (2015) 0.80
Expression, assembly competence and antigenic properties of hepatitis B virus core gene deletion variants from infected liver cells. J Gen Virol (1999) 0.80
Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope. Intervirology (1999) 0.79
Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol Chem Hoppe Seyler (1996) 0.79
Catecholamines in urine after death. Forensic Sci Int (1999) 0.78
Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments. J Gen Virol (1997) 0.78
Reference values for urinary HMMA, HVA, noradrenaline, adrenaline, and dopamine excretion in children using random urine samples and HPLC with electrochemical detection. Ann Clin Biochem (1992) 0.78
Warning device for the prevention of ischaemic ulcers in quadriplegics. Med Biol Eng (1976) 0.77
Interaction of wild-type and naturally occurring deleted variants of hepatitis B virus core polypeptides leads to formation of mosaic particles. FEBS Lett (2000) 0.77
Parvovirus B19 infection associated with unilateral cervical lymphadenopathy, apoptotic sinus histiocytosis, and prolonged fatigue. J Clin Pathol (2005) 0.76
Low dose alpha interferon treatment in chronic hepatitis B virus infection. Gut (1993) 0.76
Post-translational phosphorylation affects the IgE binding capacity of caseins. FEBS Lett (2000) 0.76
A new variant of progressive encephalomyelitis with rigidity associated with cerebellar ataxia and dementia: correlation of MRI and histopathological changes. A case report. Neurol Res (1997) 0.76
[Treatment of chronic hepatitis B with interferon alpha-2b]. Gastroenterol J (1990) 0.76
Interpretation of random urinary catecholamines and their metabolites in neuroblastoma. Acta Paediatr (1994) 0.75
Dysregulated Epstein-Barr virus infection in patients with CIDP. J Neuroimmunol (2009) 0.75
Acrylamide-occurrence in mixed concentrate feed for dairy cows and carry-over into milk. Food Addit Contam (2005) 0.75
[Vinomin, an additional alkaloid of Vinca minor]. Pharmazie (1971) 0.75
Comparison of direct and indirect two-site binding enzyme immunoassay. Clin Chim Acta (1982) 0.75
[Anaerobic bacteremia and septicemia]. Przegl Epidemiol (1975) 0.75
[Pathogenic role of various pleomorphic gram-negative bacteria]. Przegl Epidemiol (1976) 0.75
[Gram-negative, rod-like, asporogenic anaerobes and diseases caused by them]. Pol Tyg Lek (1977) 0.75
Thermal response of paraplegic skin to the application of localized pressure. Arch Phys Med Rehabil (1981) 0.75
[Structure and stereochemistry of (-)-10-oxominovincin]. Pharmazie (1971) 0.75
[Diseases caused by some Gram-negative pleomorphic microaerophilic organisms and absolute anaerobes]. Pol Tyg Lek (1976) 0.75
Short communication: bovine kappa-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides. J Dairy Sci (2009) 0.75
[Clinical studies on evaluation of the TNM classification of the oral carcinoma]. Dtsch Zahnarztl Z (1973) 0.75
[In Memoriam: Professor and Doctor in Medical Sciences Stanislaw Legezyński]. Postepy Hig Med Dosw (1971) 0.75
[The mechanism of anaerobic gastrointestinal infection in man]. Pol Tyg Lek (1974) 0.75
Nutraceutical and functional food ingredients for food and pharmaceutical applications. Br J Nutr (2001) 0.75
[Risk of hepatitis B in endoscopy personnel]. Dtsch Z Verdau Stoffwechselkr (1981) 0.75
[Anaerobic organisms, bacteremia and septicemia]. Pol Tyg Lek (1975) 0.75
[Studies on the type E of Clostridium botulinum. V. Hemolytic activity of the type E of botulinum toxin]. Med Dosw Mikrobiol (1965) 0.75
Natural history of hepatitis C. Mem Inst Oswaldo Cruz (2000) 0.75
[Bacteroides fragilis and its role in infections]. Pol Tyg Lek (1978) 0.75
Whey protein isolate polydispersity affects enzymatic hydrolysis outcomes. Food Chem (2013) 0.75
In vitro generation and stability of the lactokinin beta-lactoglobulin fragment (142-148). J Dairy Sci (2004) 0.75